Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.

Stafford RS, Monti V, Ma J.

PLoS Med. 2005 Dec;2(12):e353. Epub 2005 Nov 15.

PMID:
16277554
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

Morimoto T, Fukui T, Lee TH, Matsui K.

Am J Med. 2004 Oct 1;117(7):459-68. Review.

PMID:
15464702
[PubMed - indexed for MEDLINE]
3.

Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.

Jackson R.

J Hum Hypertens. 1998 Sep;12(9):607-13. Review.

PMID:
9783489
[PubMed - indexed for MEDLINE]
4.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

PMID:
12512736
[PubMed - indexed for MEDLINE]
Free Article
5.

Aspirin for primary prevention of cardiovascular disease in women.

Jneid H.

Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan;6(4):37-42. Review.

PMID:
21088658
[PubMed - indexed for MEDLINE]
6.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

PMID:
17408535
[PubMed - indexed for MEDLINE]
Free Article
7.

Aspirin for primary prevention of cardiovascular disease events.

Nemerovski CW, Salinitri FD, Morbitzer KA, Moser LR.

Pharmacotherapy. 2012 Nov;32(11):1020-35. doi: 10.1002/phar.1127. Epub 2012 Sep 27. Review.

PMID:
23019080
[PubMed - indexed for MEDLINE]
8.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
[PubMed - indexed for MEDLINE]
9.

Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.

Daviglus ML, Lloyd-Jones DM, Pirzada A.

Am J Cardiovasc Drugs. 2006;6(2):87-101. Review.

PMID:
16555862
[PubMed - indexed for MEDLINE]
10.

Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.

Wolff T, Miller T, Ko S.

Ann Intern Med. 2009 Mar 17;150(6):405-10. Review.

PMID:
19293073
[PubMed - indexed for MEDLINE]
11.

Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997.

Schappert SM.

Vital Health Stat 13. 1999 Nov;(143):i-iv, 1-39. Review.

PMID:
10633576
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D.

Acta Cardiol. 2009 Feb;64(1):1-10. Review.

PMID:
19317290
[PubMed - indexed for MEDLINE]
13.

Risk assessment and aspirin use in Asian and Western populations.

Gao R, Li X.

Vasc Health Risk Manag. 2010 Oct 21;6:943-56. doi: 10.2147/VHRM.S9400. Review.

PMID:
21057579
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Why are we failing to implement effective therapies in cardiovascular disease?

Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S.

Eur Heart J. 2013 May;34(17):1262-9. doi: 10.1093/eurheartj/ehs481. Epub 2013 Feb 1. Review.

PMID:
23376448
[PubMed - indexed for MEDLINE]
Free Article
15.

Cardiovascular disease: rise, fall, and future prospects.

Luepker RV.

Annu Rev Public Health. 2011;32:1-3. doi: 10.1146/annurev-publhealth-112810-151726. Review.

PMID:
21219158
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk